Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMARIN CORP PLC\UKAMRN · Entity 5970 | Director | June 27, 2022 | June 30, 2022 |
| Minerva Neurosciences, Inc.NERV · Entity 6245 | Director | June 03, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMARIN CORP PLC\UK
Report date June 27, 2022 · Filed June 30, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.92 · Expires 2032-06-27 | Direct | 115,919 |
Reported balance
After 2022-06-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-27 · Grant · Acquired 115,919 · Balance 115,919 F1: On June 27, 2022, the Reporting Person was granted an option to purchase 115,919 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of June 27, 2022 or (ii) the Issuer's annual general meeting of shareholders in 2023. F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 93,750 |
Reported balance
After 2022-06-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-27 · Grant · Acquired 93,750 · Balance 93,750 F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer. F4: On June 27, 2022, the Reporting Person was granted 93,750 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of June 27, 2022 or (ii) the Issuer's annual general meeting of shareholders in such year. F5: Not applicable. F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 27, 2022, the Reporting Person was granted an option to purchase 115,919 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of June 27, 2022 or (ii) the Issuer's annual general meeting of shareholders in 2023.
F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer.
F4: On June 27, 2022, the Reporting Person was granted 93,750 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of June 27, 2022 or (ii) the Issuer's annual general meeting of shareholders in such year.
F5: Not applicable.
Minerva Neurosciences, Inc.
Report date June 03, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.68 · Expires 2036-06-02 | Direct | 50,000 |
Reported balance
After 2026-06-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-03 · Grant · Acquired 50,000 · Balance 50,000 F1: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 5, 2026 22:00 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001021040-26-000002 · form4-06052026_060603.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-06-02 F1 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:15 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001021040-25-000004 · form4-12232025_041213.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-12-21 F1 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following December 22, 2025 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| December 05, 2024 Filed Dec 6, 2024 22:45 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001415889-24-028544 · form4-12062024_051214.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-12-04 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 12,500 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following December 5, 2024 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| September 27, 2023 Filed Sep 29, 2023 12:59 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001209191-23-050827 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-09-26 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 12,500 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following September 27, 2023 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 27, 2022 Filed Jun 30, 2022 00:07 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 93,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005405 · primarydocument.xml · derivative · entry 2 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,750 Underlying: Ordinary Shares · 93,750 shares Expires not disclosed F3 · security: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer. F4 · derivative.exercise_date: On June 27, 2022, the Reporting Person was granted 93,750 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of June 27, 2022 or (ii) the Issuer's annual general meeting of shareholders in such year. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 27, 2022 Filed Jun 30, 2022 00:07 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 115,919 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001562180-22-005405 · primarydocument.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,919 Underlying: Ordinary Shares · 115,919 shares Expires 2032-06-27 F1 · derivative.exercise_date: On June 27, 2022, the Reporting Person was granted an option to purchase 115,919 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of June 27, 2022 or (ii) the Issuer's annual general meeting of shareholders in 2023. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 10, 2022 Filed Jun 28, 2022 23:33 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $3.32 | $0.00 |
DisclosureSEC source: 0001209191-22-039685 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2032-06-09 F1 · security: This option is granted to non-employee directors in accordance with the Issuer's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 2,500 shares of common stock per year. F2 · derivative.exercise_price: On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock ("Reverse Stock Split"). This amount has been adjusted to give effect to the Reverse Stock Split. F2 · shares: On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock ("Reverse Stock Split"). This amount has been adjusted to give effect to the Reverse Stock Split. F3 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 10, 2022 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. F2 · derivative.underlying_shares: On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock ("Reverse Stock Split"). This amount has been adjusted to give effect to the Reverse Stock Split. F2 · balance_after: On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock ("Reverse Stock Split"). This amount has been adjusted to give effect to the Reverse Stock Split. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 00:06 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 36,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004329 · primarydocument.xml · derivative · entry 2 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Ordinary Shares · 36,000 shares Expires not disclosed F3 · security: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer. F4 · derivative.exercise_date: On June 14, 2021, the Reporting Person was granted 36,000 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of June 14, 2021 or (ii) the Issuer's annual general meeting of shareholders in such year. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 00:06 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 45,953 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004329 · primarydocument.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,953 Underlying: Ordinary Shares · 45,953 shares Expires 2031-06-14 F1 · derivative.exercise_date: On June 14, 2021, the Reporting Person was granted an option to purchase 45,953 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of June 14, 2021 or (ii) the Issuer's annual general meeting of shareholders in 2022. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:47 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-21-040683 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| September 10, 2020 Filed Sep 11, 2020 21:13 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | PurchaseCommon Stock | 7,000 | $2.97 | $20,790.00 |
DisclosureSEC source: 0001209191-20-050176 · doc4.xml · nonDerivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,333 Read SEC document |
| July 13, 2020 Filed Jul 16, 2020 00:08 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 27,191 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-005126 · primarydocument.xml · derivative · entry 2 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,191 Underlying: Ordinary Shares · 27,191 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer. F4 · derivative.exercise_date: On July 13, 2020, the Reporting Person was granted 27,191 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of July 13, 2020 or (ii) the Issuer's annual general meeting of shareholders in such year. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 13, 2020 Filed Jul 16, 2020 00:08 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 34,805 | $0.00 Strike: $6.62 | $0.00 |
DisclosureSEC source: 0001562180-20-005126 · primarydocument.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,805 Underlying: Ordinary Shares · 34,805 shares Expires 2030-07-13 F1 · derivative.exercise_date: On July 13, 2020, the Reporting Person was granted an option to purchase 34,805 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of July 13, 2020 or (ii) the Issuer's annual general meeting of shareholders in 2021. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 21:02 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001209191-20-036342 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 26, 2019 Filed Jun 27, 2019 20:30 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | PurchaseCommon Stock | 10,000 | $5.37 | $53,700.00 |
DisclosureSEC source: 0001209191-19-039271 · doc4.xml · nonDerivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,333 Read SEC document |
| May 31, 2019 Filed May 31, 2019 21:42 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.21 | $0.00 |
DisclosureSEC source: 0001209191-19-033707 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-30 F1 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following May 31, 2019 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| May 20, 2019 Filed May 22, 2019 00:10 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 7,428 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031864 · doc4.xml · derivative · entry 2 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,428 Underlying: Ordinary Shares · 7,428 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer. F4 · derivative.exercise_date: On May 20, 2019, the Reporting Person was granted 7,428 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of May 20, 2019 or (ii) the Issuer's annual general meeting of shareholders in such year. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| May 20, 2019 Filed May 22, 2019 00:10 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 9,658 | $0.00 Strike: $16.83 | $0.00 |
DisclosureSEC source: 0001209191-19-031864 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,658 Underlying: Ordinary Shares · 9,658 shares Expires 2029-05-20 F1 · derivative.exercise_date: On May 20, 2019, the Reporting Person was granted an option to purchase 9,658 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of May 20, 2019 or (ii) the Issuer's annual general meeting of shareholders in 2020. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 28,847 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-19-012807 · doc4.xml · derivative · entry 9 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 28,847 shares Expires 2026-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option granted to the Reporting Person is fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 28,500 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001209191-19-012807 · doc4.xml · derivative · entry 8 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 28,500 shares Expires 2024-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option granted to the Reporting Person is fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $14.40 | $0.00 |
DisclosureSEC source: 0001209191-19-012807 · doc4.xml · derivative · entry 7 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 45,000 shares Expires 2022-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option granted to the Reporting Person is fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001209191-19-012807 · doc4.xml · derivative · entry 6 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 90,000 shares Expires 2020-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option granted to the Reporting Person is fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 203,382 | $20.02 | $4,071,422.91 |
DisclosureSEC source: 0001209191-19-012807 · doc4.xml · nonDerivative · entry 5 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,168 F1 · security: The option exercise and sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 28,847 | $2.19 | $63,174.93 |
DisclosureSEC source: 0001209191-19-012807 · doc4.xml · nonDerivative · entry 4 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercise and sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 28,500 | $1.87 | $53,295.00 |
DisclosureSEC source: 0001209191-19-012807 · doc4.xml · nonDerivative · entry 3 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercise and sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 45,000 | $14.40 | $648,000.00 |
DisclosureSEC source: 0001209191-19-012807 · doc4.xml · nonDerivative · entry 2 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercise and sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 90,000 | $1.03 | $92,700.00 |
DisclosureSEC source: 0001209191-19-012807 · doc4.xml · nonDerivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercise and sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:40 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $8.25 | $0.00 |
DisclosureSEC source: 0001209191-18-036991 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-06 F1 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 7, 2018 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| May 14, 2018 Filed Oct 2, 2018 23:12 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 31,153 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-053482 · doc4.xml · derivative · entry 2 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,153 Underlying: Ordinary Shares · 31,153 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer. F4 · derivative.exercise_date: On May 14, 2018, the Reporting Person was granted 31,153 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of May 14, 2018 or (ii) the Issuer's annual general meeting of shareholders in such year. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| May 14, 2018 Filed Oct 2, 2018 23:12 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (right to buy) · Derivative | 46,973 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001209191-18-053482 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,973 Underlying: Ordinary Shares · 46,973 shares Expires 2028-05-14 F1 · derivative.exercise_date: On May 14, 2018, the Reporting Person was granted an option to purchase 46,973 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of May 14, 2018 or (ii) the Issuer's annual general meeting of shareholders in 2019. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 21:08 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037806 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 1, 2017 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| May 15, 2017 Filed May 17, 2017 21:24 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 14,706 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-033272 · doc4.xml · derivative · entry 2 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,706 Underlying: Ordinary Shares · 14,706 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer. F4 · derivative.exercise_date: On May 15, 2017 the Reporting Person was granted 14,706 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of May 15, 2017 or (ii) the Issuer's annual general meeting of shareholders in such year. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| May 15, 2017 Filed May 17, 2017 21:24 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (right to buy) · Derivative | 21,146 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001209191-17-033272 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,146 Underlying: Ordinary Shares · 21,146 shares Expires 2027-05-15 F1 · derivative.exercise_date: On May 15, 2017, the Reporting Person was granted an option to purchase 21,146 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of May 15, 2017 or (ii) the Issuer's annual general meeting of shareholders in 2018. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.